ebook: Accelerate vaccine development
Our comprehensive portfolio suite is designed to optimize your productivity to get safe and efficacious vaccines and therapeutics to market faster.
List view / Grid view
Our comprehensive portfolio suite is designed to optimize your productivity to get safe and efficacious vaccines and therapeutics to market faster.
Drug Target Review brings you five of the most recent developments in three-dimensional (3D) bioprinting.
The development of a Parkinson’s disease model, using hiPSC-derived neural cells, to assess alpha-synuclein pre-formed fibril-induced toxicity.
Researchers have developed a vaccine using stem cells that protected mice injected with pancreatic cancer cells from developing tumours.
Researchers have shown that Chroman 1, Emricasan and trans-ISRIB, in combination with polyamines, are effective at protecting induced pluripotent stem cells from stress.
Researchers have created a new imaging technique called electrochemiluminescence to visualise multiple spheroids with a single shot.
In this short video we show an example of a 3D airway organoid model along with some interesting ways to get the most out of this type of assay.
Researchers have developed the first 3D organoid models of the pancreas that includes both the acinar and ductal structures.
Researchers have developed a stem cell therapy that could treat the damage caused by dementia by launching a repair response.
An international collaboration has led to the development of monkey embryos able to grow with injected human stem cells.
14 April 2021 | By Fluidigm
Watch our free on-demand webinar to learn more about using Imaging Mass Cytometry™ (IMC™) to measure over 40 protein targets with subcellular resolution.
Scientists have visualised the spatial and temporal distribution of neural stem cell activation in zebrafish models.
Discover how a new ELISA against S1-RBD for COVID-19 seroconversion detection can accelerate discovery to facilitate vaccine breakthroughs.
A team has developed a lotus-root-shaped construct to deliver iPSC-derived pancreatic beta-cells to patients with type I diabetes mellitus.
A team has designed gold nanoparticles to reveal specific bone stem cells, which could lead to treatments for major bone fractures.